Schedule

Phage Therapy for the Treatment of Periprosthetic Joint Infection: A Canadian Experience

1:00 - 1:05 PM PhageSTAR: Developing a National Program for Phage Susceptibility Testing in Canada (Steven Gayder) 1:05 - 1:10 PM Decoding Streptococcus suis Prophage Lysins: A Systematic Investigation of Their Diversity and Functional Relationships (Azat Bikmullin) 1:10 - 1:15 PM Bacteriophages against Exudative Epidermitis (EE): From isolation to therapeutic application in the swine industry (Mousumi Sarker Chhanda) 1:15 - 1:20 PM QA panel

1:30 - 1:35 PM Identifying Key Mycobacteriophage Charlie Genes and Host Interactions that Affect Mycobacterium smegmatis Growth (Rebecca Santhosh Babu) 1:35 - 1:40 PM Development of a Phage Cocktail for Controlling Salmonella in Poultry (Brandon Spoja) 1:40 - 1:45 PM Temperate phages can re-sensitize multi-drug resistant Pseudomonas aeruginosa to antibiotics (Rabia Fatima) 1:45 - 1:50 PM QA panel

1:50 - 2:10 PM Synergy between ciprofloxacin and temperate phages overcomes limitations caused by lysogen formation (Philip Lauman) 2:10 - 2:30 PM Understanding the drivers of phage-resistance of uropathogenic E. coli ST131 in urine (Alba Park de la Torriente)